Accéder au contenu
Merck

Synthesis of novel phosphorylated guanidine derivatives from cyanamide and their anti-inflammatory activity.

Chemical & pharmaceutical bulletin (2013-01-11)
Venkata Ramana Katla, Rasheed Syed, Chandra Sekhar Kuruva, Hema Kumar Kuntrapakam, Naga Raju Chamarthi
RÉSUMÉ

A series of novel guanidine derivatives were synthesized in three steps and their anti-inflammatory activities in vitro and in vivo evaluated. 2-Aminopyridin-3-ol (1) was reacted with thiophosphoryl chloride (2) to give a monochloride (3). It was further reacted with cyanamide to afford the corresponding cyanamine (4), which was subsequently reacted with different heterocyclic amines to form the title compounds (5a-l). The substituent in the guanidine function affected the potency of anti-inflammatory activity. The compounds having benzothiazole, fluorophenyl, and piperazinyl moieties enhanced the anti-inflammatory activity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Guanidine hydrochloride, for molecular biology, ≥99%
Sigma-Aldrich
Guanidine hydrochloride, ≥98%
Sigma-Aldrich
Guanidine hydrochloride, organic base and chaeotropic agent, ≥99% (titration)
Sigma-Aldrich
Cyanamide, 99%
Sigma-Aldrich
Guanidine hydrochloride solution, Colorless liquid, 7.8 - 8.3 M, pH- 4.5 - 5.5
Sigma-Aldrich
Guanidine hydrochloride solution, BioUltra, ~8 M in H2O
Sigma-Aldrich
Guanidine hydrochloride, ≥99.0% (AT)
Sigma-Aldrich
Guanidine hydrochloride, BioUltra, for molecular biology, ≥99.5% (AT)
Sigma-Aldrich
Cyanamide solution, 50 wt. % in H2O
Sigma-Aldrich
Calcium cyanamide, technical grade